These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7657849)

  • 1. Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol.
    Gupta SK; Okerholm RA; Eller M; Wei G; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 May; 35(5):493-8. PubMed ID: 7657849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).
    Gorsline J; Gupta SK; Dye D; Rolf CN
    J Clin Pharmacol; 1993 Feb; 33(2):161-8. PubMed ID: 8440766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
    Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
    Gupta SK; Okerholm RA; Coen P; Prather RD; Gorsline J
    J Clin Pharmacol; 1993 Feb; 33(2):169-74. PubMed ID: 8440767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise.
    Homsy W; Yan K; Houle JM; Besner JG; Gossard D; Pierce CH; Caillé G
    J Clin Pharmacol; 1997 Aug; 37(8):728-36. PubMed ID: 9378845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men.
    Prather RD; Tu TG; Rolf CN; Gorsline J
    J Clin Pharmacol; 1993 Jul; 33(7):644-9. PubMed ID: 8366189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma nicotine concentrations after application of nicoderm (nicotine transdermal system) to different skin sites.
    Gorsline J; Okerholm RA; Rolf CN; Moos CD; Hwang SS
    J Clin Pharmacol; 1992 Jun; 32(6):576-81. PubMed ID: 1634647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers.
    Kochak GM; Sun JX; Choi RL; Piraino AJ
    Pharm Res; 1992 Nov; 9(11):1451-5. PubMed ID: 1475232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
    Benowitz NL; Zevin S; Jacob P
    Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm).
    Jordan WP
    J Fam Pract; 1992 Jun; 34(6):709-12. PubMed ID: 1593244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditions.
    Caspary S; Keller-Stanislawski B; Huber T; Merz PG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):92-5. PubMed ID: 2071260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting.
    Gariti P; Alterman AI; Barber W; Bedi N; Luck G; Cnaan A
    Drug Alcohol Depend; 1999 Apr; 54(2):111-6. PubMed ID: 10217550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.
    Ross HD; Chan KK; Piraino AJ; John VA
    Pharm Res; 1991 Mar; 8(3):385-8. PubMed ID: 2052530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
    Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J
    Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of buccal exposure to dermal nicotine patches in the dog: a comparative evaluation.
    Herman EH; Vick JA; Strong JM; Parker RJ; Geyer HM; Kramer ED; Higgins KM; Sistare FD
    J Toxicol Clin Toxicol; 2001; 39(2):135-42. PubMed ID: 11407499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine administration in rabbits using Habitrol nicotine patches and nicotine nasal spray.
    Sipe RV; Buck DC; Hollinger JO
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):480-2. PubMed ID: 10874502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems.
    Dubois JP; Sioufi A; Müller P; Mauli D; Imhof PR
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):187-95. PubMed ID: 2725117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette.
    Yuki D; Kikuchi A; Miura N; Kakehi A; Onozawa M
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):240-5. PubMed ID: 23933006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.